Navigation Links
Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
Date:5/20/2008

that utilizes MMX(R) Technology. LIALDA with MMX Technology combines a pH dependent gastro-resistant coating, which delays the release of the medication to the colon (the site of the inflammation in ulcerative colitis), with a tablet core containing mesalamine with hydrophilic and lipophilic components.

Shire has licensed from Giuliani SpA the exclusive rights to develop and commercialize LIALDA in the US, Canada, Pacific Rim, and Europe (excluding Italy). LIALDA is known as MEZAVANT XL(TM) in the UK and Ireland, and MEZAVANT(R) elsewhere outside of the US. Giuliani SpA retains the development and commercialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the MMX technology.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger, and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

For further information please contact:

Media Sarah McGee (GolinHarris) +1 312 729 4125

Matthew Cabrey (Shire) +1 484 595 8248

About DDW

DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscop
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... OF SPAIN, Trinidad and Tobago , July ... Division of the Trinidad & Tobago Ministry of ... market, an innovative therapy that significantly increases the cure ... for patients infected with the genotype 1 virus. ... under the trade brand INCIVO®. ...
(Date:7/25/2014)... , July 25, 2014  Solanbridge Group Inc ... acquired the majority interest in Buzznbrewz.com and the Letter ... replaced with a fully executed Purchase Agreement. ... stated "We are proud to have Mr. David ... decades of experience in the private sector and developed ...
(Date:7/25/2014)... 25, 2014 Research and Markets ... Diagnostic Devices Market 2014-2018" report to their offering. ... About Ophthalmic Diagnostic Device An ophthalmic ... a defect or deficiency in the human visual pathway. ... such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... Sept. 21, 2011 A new electronic medication system, the ... Hospital for Children at P/SL which adds a new ... right amount of medicine in an emergency situation. ... up calculations and reduce mistakes.  Dr. James Broselow, inventor of ...
... Research Partners is pleased to announce the recent closing ... Heart is a Minnesota-based medical device company that is ... contacting, heart assist therapy for the treatment of moderate ... a minimally invasive procedure. Sunshine Heart ...
Cached Medicine Technology:New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 2New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 3
(Date:7/26/2014)... Pools can provide much-needed relief from the summer heat, ... too much chlorinated water, experts warn. Amid the ... get water in their mouth. Some kids may even ... their parents. Although swallowing a small amount of ... realize that ingesting too much can lead to chlorine ...
(Date:7/26/2014)... As reported by Lauren Hunter ... on 3 factors: smaller spaces, multi-generational access, and water ... of 2014 lists, including this article on Freshome ... , a leading manufacturer of steam bath generators, has ... to smaller spaces and an effort to reduce water ...
(Date:7/26/2014)... As reported in this article ... research by Palo Alto Networks shows that Nigeria’s infamous ... focusing more on businesses and their digital treasures instead ... wise to their tactics over the years. Global ... talks about the evolution of 419 scams and what ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 “Healthy teeth are ... keeping those pearly whites shining,” says Community Health Center of ... Healthy ." , They believe that an integration of medical ... healthy and well. Because of this, they encourage regular cleanings ... with dentist . , “Children and adults will find ...
(Date:7/26/2014)... Dallas, TX (PRWEB) July 26, 2014 ... sclerosis or encephalomyelitis disseminata, is an inflammatory disease ... in the brain and spinal cord are damaged. ... the nervous system to communicate, resulting in a ... mental, and sometimes psychiatric problems. Multiple sclerosis takes ...
Breaking Medicine News(10 mins):Health News:Don't Let Kids Drink Pool Water 2Health News:Amerec Finds Bathroom Design Trends Change Based on Water Consumption and Other Factors 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 3Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 4Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 5Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 6Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4
... (NYSE: ACS ) announced today that it ... provide information technology,outsourcing (ITO) services to Parkland Health ... Under the terms of the agreement, ACS will ... and management, asset tracking, and help desk support ...
... have correlated with prostate biopsy results in the detection ... for men with a normal prostate exam, according to ... issue of CANCER, a peer-reviewed journal of the American ... make PSA less useful in prostate cancer screening. , ...
... in Drosophila (fruit flies), have identified several drugs and small ... a frequent form of mental retardation and one of the ... stage for developing new treatments for fragile X syndrome. , ... PhD, chair of the Department of Human Genetics at Emory ...
... stretching program still evident 3 months later, study ... helps ease hot flashes and other menopausal symptoms in ... of the 37 women who,d had early stage breast ... program, while others were assigned to a control group. ...
... FRANCISCO Only 45 percent of baseball players were able ... level after shoulder or elbow surgery, according to new research ... Medicine Specialty Day at The Moscone Center. , ... percent of the players back to their pre-injury level or ...
... New research found only 45 percent of players return to same or higher ... ... percent of baseball,players were able to return to the game at the same ... during,the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at,The Moscone Center., ...
Cached Medicine News:Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 2Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 3Health News:Biopsy techniques have made PSA test less predictive 2Health News:Drosophila drug screen for fragile X syndrome finds promising compounds and potential drug targets 2Health News:Yoga Eases Menopause Symptoms in Breast Cancer Survivors 2Health News:Comeback to a pre-injury level disappointing for professional baseball players 2Health News:Comeback to a Pre-Injury Level After Elbow or Shoulder Surgery Disappointing for Pro Baseball Players 2
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Microsurgical curved forceps made of titanium has curved shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Girard curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 99 mm....
Angled tying forceps made of titanium has angled shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 102 mm....
Medicine Products: